Author’s Guidelines 2020

Aims and Scope

Psychopharmacology Bulletin publishes full-length research articles, review articles, brief reports, clinical case studies, commentary, and letters. Manuscripts submitted to Bulletin’s new section, Negative and Failed Clinical Trial Reports will be entitled to fast-track review. Psychopharmacology Bulletin is committed to the highest ethical standards in medical research. Accordingly, we ask authors to provide specific information regarding ethical treatment of research participants, patient consent, patient privacy, protocols, authorship, and competing interests. We also ask that reports of certain specific types of studies adhere to generally accepted standards. Our requirements are based on the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, issued by the International Committee for Medical Journal Editors. (http://www.icmje.org/)

Manuscript Submission

Manuscript files can be in the following formats: DOC, DOCX, or PDF. Microsoft Word documents should not be locked or protected. An electronic file of manuscripts (including all illustrations and tables) should be submitted to editorial@medworksmedia.com, or sent to MedWorks Media’s submission receiving address:

MedWorks Media Inc.
2205 Rockefeller Lane, Bldg. B
Redondo Beach CA. 90278
Tel: 310-374-4200

Manuscripts for consideration by Psychopharmacology Bulletin must be submitted solely to Psychopharmacology Bulletin, and may not have been published in another publication of any type, professional or lay. Manuscripts will be reviewed by a member of the Editorial Board, depending on the principle topic and focus of the submission. The journal will not be responsible for loss of manuscripts at any time. Upon acceptance of a manuscript for publication, the corresponding author will be required to sign an agreement transferring copyright to the publisher. All such manuscripts become the property of the publisher, and no material published in the journal may be reproduced or published elsewhere without written permission from the publisher, who reserves copyright.

Any possible conflict of interest, financial or otherwise, related to the submitted work must be clearly indicated in the manuscript, or in a cover letter accompanying the submission. All statements in, or omissions from, published manuscripts are the responsibility of the authors, who will be asked to review proofs prior to publication. Reprint order forms will be sent with the page proofs. No page charges will be levied against authors or their institutions for publication in Psychopharmacology Bulletin.

Format of Manuscript Elements

Manuscripts must be in English with wide (1 inch) margins, typed and double-spaced throughout. Number pages consecutively. Manuscripts should contain each of the following elements in sequence: 1) title page, 2) abstract, 3) text, 4) acknowledgements, 5) references, 6) tables, and 7) figure legends. Start each subdivision on a new page. Define abbreviations at the first mention in the text. Manuscripts should be prepared using American Medical Association style. Use generic drug names in the text. The text should be written in a uniform style, and its contents as submitted for consideration should be deemed final by the author and suitable for publication as follows:

Title Page

The title page should contain the complete title of the manuscript, author names with degrees, and each author’s title(s) and affiliation, institution(s) at which the work was performed, and name, address, telephone, and tel/fax numbers, and e-mail address of the author responsible for correspondence. Authors should also provide a short title of not more than 45 characters (including spaces), and 5 to 10 key words, not in the title but taken from Index Medicus, that will highlight the subject matter of the article.

Abstract

Abstracts must be 250 words or less, and should be intelligible without reference to the text. Objectives, experimental design, principal observations, and conclusions should be succinctly summarized for research articles, brief reports, and reviews.

Research articles

There are no restrictions on the number of pages or figures. Introduction, Materials and Methods, Results, Discussion, and Conclusion sections conforming to standard scientific reporting style are required (where appropriate, Results and Discussion may be combined). Research articles should include a hypothesis. Detailed information on statistics should be provided such as name of statistical test, whether tests were one-or two-tailed, test used for each set of data, and correction factors, if any, for multiple comparisons. Data and figures should present or reflect standard deviations rather than standard error of means. All significant and relevant nonsignificant results must include test values, degree(s) of freedom, and probability.

Brief reports

Brief reports are intended for presentation of data on research projects which have progressed to a point where preliminary observations should be disseminated (eg, pilot studies, initial drug trials, significant findings in need of replication). Brief reports may not exceed four printed pages (approximately six double-spaced manuscript pages, inclusive of text, references, figures, and legends). Section headings are not necessary. Concise abstracts should be included.

Review articles

Review and theoretical articles are usually invited, but submitted reviews or theory-oriented articles will be considered. Such articles should provide a critical review and interpretation of the literature and current research directions in a given area. An abstract is required. The text should flow smoothly, and subdivisions (eg, Introduction, Methods, Results) within the manuscript are not necessary. There are no a priori page limitations for reviews or theoretical papers; however, proposals for papers of this nature should be directed to the Psychopharm